Preventing fetal damage from sexually transmitted diseases. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Preventing fetal damage from sexually transmitted diseases.

Clin Obstet Gynecol. 1991 Jun;34(2):336-44. Unique Identifier : AIDSLINE MED/91330471
Minkoff HL; Department of Obstetrics & Gynecology, SUNY-Health Science; Center, Brooklyn 11203-2098.

Abstract: The STDs threaten the reproductive health of women in many ways, ranging from premature births through congenital infections and death. An understanding of the natural history of these diseases permits timely interventions which can mitigate the perinatal damage caused by these infections substantially. Ideally, primary prevention or safer sex will be adopted by sexually active women, thereby reducing the morbidity not only for their offspring but for themselves as well. Antiviral therapy is not yet available for minimizing any hazard of fetal exposure to HPV, HSV, HIV, and hepatitis B viral infections. Early antibiotic therapy should reduce the risk of congenital syphilis and any perinatal hazards associated with chlamydial and gonococcal infections.
Keywords: Antibiotics/THERAPEUTIC USE Female Fetal Diseases/DRUG THERAPY/MICROBIOLOGY/*PREVENTION & CONTROL Hepatitis B/DRUG THERAPY/PREVENTION & CONTROL Herpes Simplex/DRUG THERAPY/PREVENTION & CONTROL Human HIV Infections/DRUG THERAPY/PREVENTION & CONTROL Infant, Newborn Pregnancy Primary Prevention *Sexually Transmitted Diseases/DRUG THERAPY/PREVENTION & CONTROL JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL

KWDantibiotics/therapeuticusefemalefetaldiseases/drugtherapy/microbiology/KWDprevention&controlhepatitisb/drugtherapy/prevention&controlherpessimplex/drugtherapy/prevention&controlhumanhivinfections/drugtherapy/prevention&controlinfant,newbornpregnancyprimarypreventionKWDsexuallytransmitteddiseases/drugtherapy/prevention&controljournalarticlereviewreview,tutorial
911130
M91B0532

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .